These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24295522)

  • 21. Clinical Significance of Phase Angle in Non-Dialysis CKD Stage 5 and Peritoneal Dialysis Patients.
    Han BG; Lee JY; Kim JS; Yang JW
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD.
    Tsai YC; Chiu YW; Tsai JC; Kuo HT; Hung CC; Hwang SJ; Chen TH; Kuo MC; Chen HC
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):39-46. PubMed ID: 25512646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predialysis NTproBNP predicts magnitude of extracellular volume overload in haemodialysis patients.
    Nongnuch A; Panorchan K; Davenport A
    Am J Nephrol; 2014; 40(3):251-7. PubMed ID: 25322897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Greater fluid overload and lower interdialytic weight gain are independently associated with mortality in a large international hemodialysis population.
    Hecking M; Moissl U; Genser B; Rayner H; Dasgupta I; Stuard S; Stopper A; Chazot C; Maddux FW; Canaud B; Port FK; Zoccali C; Wabel P
    Nephrol Dial Transplant; 2018 Oct; 33(10):1832-1842. PubMed ID: 29688512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ghrelin and acyl ghrelin levels are associated with inflammatory and nutritional markers and with cardiac and vascular dysfunction parameters in hemodialysis patients.
    Rusu CC; Racasan S; Moldovan D; Potra A; Tirinescu D; Budurea C; Orasan R; Patiu IM; Bondor C; Vladutiu D; Delean D; Danu A; Kacso IM
    Int Urol Nephrol; 2018 Oct; 50(10):1897-1906. PubMed ID: 30006785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.
    Sommerer C; Giannitsis E; Schwenger V; Zeier M
    Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
    Paniagua R; Ventura MD; Avila-Díaz M; Hinojosa-Heredia H; Méndez-Durán A; Cueto-Manzano A; Cisneros A; Ramos A; Madonia-Juseino C; Belio-Caro F; García-Contreras F; Trinidad-Ramos P; Vázquez R; Ilabaca B; Alcántara G; Amato D
    Nephrol Dial Transplant; 2010 Feb; 25(2):551-7. PubMed ID: 19679559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-type natriuretic peptide levels and volume status in twice-weekly hemodialysis patients.
    Fang N; Che M; Shi L; Yu Z; Ni Z; Fang W; Pang H; Gu L; Lin X
    Ren Fail; 2021 Dec; 43(1):1259-1265. PubMed ID: 34465266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do Pre-Hemodialysis Estimates of Extracellular Volume Excess Using Bioimpedance and N-Terminal Brain Natriuretic Peptide Correlate With Cardiac Chamber Size Measured by Magnetic Resonance Imaging?
    Yoowannakul S; Kotecha T; Fontana M; Davenport A
    Ther Apher Dial; 2019 Aug; 23(4):362-368. PubMed ID: 30467978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
    Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
    Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of the impact of fluid overload and fluid depletion for all-cause and cardiovascular mortality.
    Siriopol D; Siriopol M; Stuard S; Voroneanu L; Wabel P; Moissl U; Voiculescu D; Covic A
    Nephrol Dial Transplant; 2019 Aug; 34(8):1385-1393. PubMed ID: 30624712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Hydration Status in Peritoneal Dialysis Patients: Validity, Prognostic Value, Strengths, and Limitations of Available Techniques.
    Alexandrou ME; Balafa O; Sarafidis P
    Am J Nephrol; 2020; 51(8):589-612. PubMed ID: 32721969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of fluid overload on heart rate variability in chronic kidney disease patients on hemodialysis.
    Ferrario M; Moissl U; Garzotto F; Cruz DN; Clementi A; Brendolan A; Tetta C; Gatti E; Signorini MG; Cerutti S; Ronco C
    BMC Nephrol; 2014 Feb; 15():26. PubMed ID: 24490775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of fluid status and inflammation and their interaction on survival: a study in an international hemodialysis patient cohort.
    Dekker MJ; Marcelli D; Canaud BJ; Carioni P; Wang Y; Grassmann A; Konings CJ; Kotanko P; Leunissen KM; Levin NW; van der Sande FM; Ye X; Maheshwari V; Usvyat LA; Kooman JP;
    Kidney Int; 2017 May; 91(5):1214-1223. PubMed ID: 28209335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac Troponin T and Hydration Status as Prognostic Markers in Hemodialysis Patients.
    Hoppe K; Schwermer K; Klysz P; Radziszewska D; Sawatiuk P; Baum E; Kaczmarek J; Roszak M; Kaluzna M; Lindholm B; Pawlaczyk K; Oko A
    Blood Purif; 2015; 40(2):139-45. PubMed ID: 26184399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low triiodothyronine is associated with elevation of N-terminal pro-brain natriuretic peptide (NT-proBNP) and mortality in dialysis patients.
    Prado-Uribe MDC; Ventura MD; Ávila-Díaz M; Mora CJ; Méndez-Durán A; Villanueva-Noches D; Cisneros A; Ilabaca B; Cueto-Manzano A; García-Contreras F; Lindholm B; García-López E; Paniagua R
    Nefrologia; 2017; 37(6):598-607. PubMed ID: 28755902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis.
    Kaysen GA; Müller HG; Young BS; Leng X; Chertow GM
    J Ren Nutr; 2004 Apr; 14(2):72-81. PubMed ID: 15060871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients?
    Papakrivopoulou E; Lillywhite S; Davenport A
    Nephrol Dial Transplant; 2012 Jan; 27(1):396-401. PubMed ID: 21765049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.